Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/20160
Title
SEOM guidelines for cervical cancer
Author(s)
Date issued
2015-12
Citation
Oaknin A, Rubio MJ, Redondo A, De Juan A, Cueva Banuelos JF, Gil-Martin M, et al. SEOM guidelines for cervical cancer. Clin Transl Oncol. 2015 Dec;17(12):1036-42. Epub 2015 Dec 9.
Language
Inglés
Document type
research article
Abstract
Cervical cancer (CC) is the second most common cancer worldwide, strongly linked to high-risk human papilloma virus infection. Although screening programs have led to a relevant reduction in the incidence and mortality due to CC in developed countries, it is still an important cause of mortality in undeveloped countries. Clinical stage is still the most relevant prognostic factor. In early stages, the primary treatment is surgery or radiotherapy, whereas concomitant chemo-radiotherapy is the conventional approach in locally advanced stages. In the setting of recurrent or metastatic CC, for the first time ever, the combination of chemotherapy plus bevacizumab prolongs the overall survival beyond 12 months. Therefore, this regimen is considered by most of the oncologist a new standard of care for metastatic/recurrent CC.
Subject
MESH
Early Detection of Cancer | Neoplasm Staging | Prognosis | Medical Oncology | Clinical Trials as Topic | Female | Societies, Medical | Humans | Combined Modality Therapy | Practice Guidelines as Topic | Uterine Cervical Neoplasms | Disease Management
DECS
Neoplasias del Cuello Uterino | Manejo de la Enfermedad | Guías de Práctica Clínica como Asunto | Humanos | Pronóstico | Ensayos Clínicos como Asunto | Femenino | Detección Precoz del Cáncer | Estadificación de Neoplasias | Sociedades Médicas | Terapia Combinada | Oncología Médica
Online version
DOI
Collections
Full text access